BiotechTV

•

Kanal • 5 Sendungen

Biowissenschaften

Biowissenschaften

25. Juni
Biowissenschaften

Biowissenschaften

Zweiwöchentlich
Biowissenschaften

Biowissenschaften

5. März
Biowissenschaften

Biowissenschaften

vor 11 Std.
Biowissenschaften

Biowissenschaften

3. Sept.

4. Mai

Episode 39: SV Health Investors' Kate Bingham

Kate Bingham describes her early life and a serendipitous opportunity to work at Vertex in the early 1990's. She then discusses joining SV Health and describes its investment approaches, the Dementia Discovery Fund, being on the UK's Vaccine Taskforce during Covid, and more.
10. Aug.

Episode 45: Catalio Capital Management's George Petrocheilos

George Petrocheilos describes going to school at Hopkins and the relationships formed there that would ultimately lead down the road to specializing in healthcare investing. He discusses starting in life sciences investing at Camden Partners, and then co-founding Catalio. Over a short period of time, keys to success have been empowering academics and entrepreneurs and expanding into multiple strategies.
27. Juli

Episode 44: BainCapital's Adam Koppel

Adam Koppel describes his career path, which included a stop at McKinsey, Biogen, and twice at Bain (where he is now). He descrbies the private equity model they have been on the leading edge of, and his take on where we are in the biotech cycle. Plus, the critical importance of mentors.
25. Juni

Episode 7: Perceptive Advisors' Joe Edelman discusses how biotech investing has changed over his extensive career, and his thoughts on running an investment firm

He describes to Matt how the market has become more efficient since he started in the 1990's. He shares his perspective on single-asset vs pipeline companies, and today's M&A dynamic. Plus, his goal of being unbiased as an investor and how he tries to create an environment at Perceptive where that style is instilled in his analysts.
24. Aug.

Episode 46: Catalys Pacific's BT Slingsby

BT Slingsby describes his education and career abroad, which ultimately led him to found and manage the largest life sciences VC firm in Japan, Catalys Pacific. He describes the dual role of taking assets from Japan and building companies around them internationally., and also in-licensing assets approved elsewhere and doing the clinical work in Japan to get them approved there. Plus, the story of the GHIT Fund, which is meant to bring Japanese innovation to neglected diseases around the world.
1. Juni

Episode 41: Forbion's Nanna Lüneborg

Nanna Luneborg discusses hear career and joining Forbion. She describes the firm's investment approach, and her experience with everything from seed, to private, and to public investing in life sciences. Plus, thoughts on China and AI in biotech.
8. Sept.

Episode 47: Ally Bridge's Andrew Lam

Andrew Lam describes his career journey that started with a Doctor of Pharmacy education before working in industry, the investment world, back in industry, and then settling at Ally Bridge. He discusses the successful investments Ally Bridge has made in biotech, including in technologies like radiopharmaceuticals and ADCs, and the concept of being a bridge to China innovation.
23. Apr.

Episode 6: BridgeBio Founder & CEO Neil Kumar discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term

He and Matt talk about portfolio construction, and the dynamics of taking on the right capital structure throughout different phases of a company's lifecycle. Neil shares early learnings from the commercial launch of Attruby, how being a commercial stage company can impact culture, and why he created the early-stage R&D focused sister company Gondola. Plus, discussing talent, intellectual property, and more.
13. Juli

Episode 43: Lightstone Venture's Mike Carusi

Mike Carusi describes his early life and career, how gaining an appreciation for sales made an impression on him early on, and his philosophy of investing in medical devices - and the similarities and differences between that and investing in therapeutics.
11. Jan.

Episode 32: ARCH Venture Partners' Bob Nelsen

While describing his early life in Washington and formative years at the University of Chicago that led to the founding of ARCH, he shares his thoughts on leadership, risk taking, changes he thinks are need to keep the United States competitive in life sciences, and his belief in AI's promise to transform our industry.

BiotechTV covers the biotechnology sector through news, stories, podcasts, and educational videos.

Channel Website

BiotechTV

Top-Sendungen

Episode 39: SV Health Investors' Kate Bingham

Episode 45: Catalio Capital Management's George Petrocheilos

Episode 44: BainCapital's Adam Koppel

Episode 7: Perceptive Advisors' Joe Edelman discusses how biotech investing has changed over his extensive career, and his thoughts on running an investment firm

Episode 46: Catalys Pacific's BT Slingsby

Episode 41: Forbion's Nanna Lüneborg

Episode 47: Ally Bridge's Andrew Lam

Episode 6: BridgeBio Founder & CEO Neil Kumar discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term

Episode 43: Lightstone Venture's Mike Carusi

Episode 32: ARCH Venture Partners' Bob Nelsen

Info

BiotechTV

Top-Sendungen

Top-Folgen

Info